tradingkey.logo

Viatris Inc

VTRS

8.810USD

0.0000.00%
收盘 08/01, 16:00美东报价延迟15分钟
10.45B总市值
亏损市盈率 TTM

Viatris Inc

8.810

0.0000.00%
关于 Viatris Inc 公司
Viatris Inc. 是一家全球医疗保健公司。该公司的部门包括发达市场、大中华区、JANZ 和新兴市场。发达市场部门主要包括其在北美和欧洲的业务。大中华区部门包括其在中国、台湾和香港的业务。JANZ 部门反映其在日本、澳大利亚和新西兰的业务。新兴市场部门涵盖其在 125 多个国家/地区的发展中市场和新兴经济体的业务,包括亚洲、非洲、东欧、拉丁美洲和中东,以及该公司的 ARV 特许经营权。该公司的产品组合包括一系列关键治疗领域的已获批准分子,包括全球公认的标志性和关键品牌和仿制药,包括复杂产品。该公司在全球设有生产基地,生产口服固体剂、注射剂和复杂剂型。
公司简介
公司代码VTRS
公司名称Viatris Inc
上市日期Feb 01, 1973
CEOMr. Scott A. Smith
员工数量32000
证券类型Ordinary Share
年结日Feb 01
公司地址1000 Mylan Boulevard
城市CANONSBURG
上市交易所NASDAQ Global Select Consolidated
国家United States of America
邮编15317
电话17245141465
网址https://www.viatris.com/en
公司代码VTRS
上市日期Feb 01, 1973
CEOMr. Scott A. Smith
公司高管
名称
名称/职务
职务
持股
持股变动
Mr. Rajiv Malik
Mr. Rajiv Malik
Director
Director
1.07M
--
Mr. Paul B. Campbell
Mr. Paul B. Campbell
Chief Accounting Officer, Corporate Controller
Chief Accounting Officer, Corporate Controller
254.46K
+13.74%
Mr. Brian Roman
Mr. Brian Roman
Chief Legal Officer
Chief Legal Officer
193.92K
--
Mr. Richard A. Mark, CPA
Mr. Richard A. Mark, CPA
Independent Director
Independent Director
91.31K
--
Mr. Wyllie Don Cornwell
Mr. Wyllie Don Cornwell
Independent Director
Independent Director
80.34K
--
Ms. Elisha W. Finney
Ms. Elisha W. Finney
Independent Director
Independent Director
37.83K
--
Ms. Theodora (Doretta) Mistras
Ms. Theodora (Doretta) Mistras
Chief Financial Officer
Chief Financial Officer
25.18K
--
Ms. JoEllen Lyons Dillon
Ms. JoEllen Lyons Dillon
Independent Director
Independent Director
--
--
Mr. Mark W. Parrish
Mr. Mark W. Parrish
Independent Vice Chairman of the Board
Independent Vice Chairman of the Board
--
--
Ms. Melina E. Higgins
Ms. Melina E. Higgins
Independent Non-Executive Chairman of the Board
Independent Non-Executive Chairman of the Board
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Mr. Rajiv Malik
Mr. Rajiv Malik
Director
Director
1.07M
--
Mr. Paul B. Campbell
Mr. Paul B. Campbell
Chief Accounting Officer, Corporate Controller
Chief Accounting Officer, Corporate Controller
254.46K
+13.74%
Mr. Brian Roman
Mr. Brian Roman
Chief Legal Officer
Chief Legal Officer
193.92K
--
Mr. Richard A. Mark, CPA
Mr. Richard A. Mark, CPA
Independent Director
Independent Director
91.31K
--
Mr. Wyllie Don Cornwell
Mr. Wyllie Don Cornwell
Independent Director
Independent Director
80.34K
--
Ms. Elisha W. Finney
Ms. Elisha W. Finney
Independent Director
Independent Director
37.83K
--
收入明细
单位: USD更新时间: 7月6日 周日
单位: USD更新时间: 7月6日 周日
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
业务USD
名称
营收
占比
Brands
2.12B
65.27%
Generics
1.13B
34.73%
地区USD
名称
营收
占比
Developed markets
1.90B
58.54%
Greater China
555.50M
17.13%
Emerging Markets
523.10M
16.13%
JANZ
277.10M
8.54%
业务
地区
业务USD
名称
营收
占比
Brands
2.12B
65.27%
Generics
1.13B
34.73%
股东统计
更新时间: 8月2日 周六
更新时间: 8月2日 周六
持股股东
股东类型
持股股东
持股股东
占比
The Vanguard Group, Inc.
12.27%
T. Rowe Price Associates, Inc.
6.19%
Davis Selected Advisers, L.P.
5.53%
BlackRock Institutional Trust Company, N.A.
5.48%
State Street Global Advisors (US)
5.24%
Other
65.29%
持股股东
持股股东
占比
The Vanguard Group, Inc.
12.27%
T. Rowe Price Associates, Inc.
6.19%
Davis Selected Advisers, L.P.
5.53%
BlackRock Institutional Trust Company, N.A.
5.48%
State Street Global Advisors (US)
5.24%
Other
65.29%
股东类型
持股股东
占比
Investment Advisor
44.92%
Investment Advisor/Hedge Fund
26.24%
Hedge Fund
6.57%
Pension Fund
2.59%
Research Firm
2.39%
Bank and Trust
1.26%
Sovereign Wealth Fund
1.06%
Individual Investor
0.26%
Family Office
0.06%
Other
14.65%
机构持股
更新时间: 7月1日 周二
更新时间: 7月1日 周二
报告期
机构数
持股数
持股占比
持股变动
2025Q2
1937
999.77M
85.18%
-69.44M
2025Q1
2006
1.01B
85.93%
-61.76M
2024Q4
2002
1.03B
86.53%
+1.20M
2024Q3
1949
989.28M
82.89%
-66.19M
2024Q2
1967
1.02B
85.33%
-16.59M
2024Q1
1986
997.86M
84.00%
-35.39M
2023Q4
2032
990.53M
82.57%
-31.15M
2023Q3
2044
970.48M
80.90%
-45.34M
2023Q2
2080
963.51M
80.35%
-35.04M
2023Q1
2188
941.77M
78.68%
-93.71M
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
The Vanguard Group, Inc.
144.00M
12.27%
+2.51M
+1.77%
Mar 31, 2025
T. Rowe Price Associates, Inc.
72.68M
6.19%
+15.75M
+27.67%
Mar 31, 2025
Davis Selected Advisers, L.P.
64.95M
5.53%
+2.37M
+3.80%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
64.32M
5.48%
+1.23M
+1.95%
Mar 31, 2025
State Street Global Advisors (US)
61.46M
5.24%
-2.29M
-3.60%
Mar 31, 2025
Geode Capital Management, L.L.C.
31.17M
2.66%
+1.11M
+3.68%
Mar 31, 2025
Deerfield Management Company, L.P.
23.99M
2.04%
-4.44K
-0.02%
Mar 31, 2025
Invesco Capital Management LLC
23.22M
1.98%
-2.85M
-10.95%
Mar 31, 2025
Columbia Threadneedle Investments (US)
21.60M
1.84%
+677.90K
+3.24%
Mar 31, 2025
Dimensional Fund Advisors, L.P.
21.26M
1.81%
+5.84M
+37.90%
Mar 31, 2025
查看更多
持股ETF
更新时间: 8月2日 周六
更新时间: 8月2日 周六
机构名称
占比
iShares U.S. Pharmaceuticals ETF
4.58%
First Trust NASDAQ Pharmaceuticals ETF
3.9%
SPDR S&P Pharmaceuticals ETF
3.81%
Franklin US Dividend Multiplier Index ETF
3.03%
Invesco Pharmaceuticals ETF
2.81%
Davis Select US Equity ETF
2.73%
Direxion Daily Pharmaceutical & Medical Bl 3X ETF
2.7%
Invesco S&P Ultra Dividend Revenue ETF
2.53%
Leatherback Long/Short Alternative Yield ETF
2.47%
Hennessy Sustainable ETF
2.24%
查看更多
iShares U.S. Pharmaceuticals ETF
占比4.58%
First Trust NASDAQ Pharmaceuticals ETF
占比3.9%
SPDR S&P Pharmaceuticals ETF
占比3.81%
Franklin US Dividend Multiplier Index ETF
占比3.03%
Invesco Pharmaceuticals ETF
占比2.81%
Davis Select US Equity ETF
占比2.73%
Direxion Daily Pharmaceutical & Medical Bl 3X ETF
占比2.7%
Invesco S&P Ultra Dividend Revenue ETF
占比2.53%
Leatherback Long/Short Alternative Yield ETF
占比2.47%
Hennessy Sustainable ETF
占比2.24%
分红派息
近5年累计派现 2.13B 美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
Feb 27, 2025
VTRS.NB Interim Cash Dividend of gross USD 0.12 paid on Mar 18, 2025 going ex on Mar 10, 2025
Mar 10, 2025
Mar 18, 2025
Mar 10, 2025
Nov 05, 2024
VTRS.NB Final Cash Dividend of gross USD 0.12 paid on Dec 13, 2024 going ex on Nov 22, 2024
Nov 22, 2024
Dec 13, 2024
Nov 22, 2024
Aug 06, 2024
VTRS.NB Interim Cash Dividend of gross USD 0.12 paid on Sep 13, 2024 going ex on Aug 23, 2024
Aug 23, 2024
Sep 13, 2024
Aug 23, 2024
May 09, 2024
VTRS.NB Interim Cash Dividend of gross USD 0.12 paid on Jun 14, 2024 going ex on May 23, 2024
May 24, 2024
Jun 14, 2024
May 23, 2024
Feb 28, 2024
VTRS.NB Interim Cash Dividend of gross USD 0.12 paid on Mar 18, 2024 going ex on Mar 08, 2024
Mar 11, 2024
Mar 18, 2024
Mar 08, 2024
Nov 08, 2023
VTRS.NB Final Cash Dividend of gross USD 0.12 paid on Dec 15, 2023 going ex on Nov 22, 2023
Nov 24, 2023
Dec 15, 2023
Nov 22, 2023
Aug 07, 2023
VTRS.NB Interim Cash Dividend of gross USD 0.12 paid on Sep 15, 2023 going ex on Aug 23, 2023
Aug 24, 2023
Sep 15, 2023
Aug 23, 2023
May 08, 2023
VTRS.NB Interim Cash Dividend of gross USD 0.12 paid on Jun 16, 2023 going ex on May 23, 2023
May 24, 2023
Jun 16, 2023
May 23, 2023
Feb 27, 2023
VTRS.NB Interim Cash Dividend of gross USD 0.12 paid on Mar 17, 2023 going ex on Mar 08, 2023
Mar 09, 2023
Mar 17, 2023
Mar 08, 2023
Nov 08, 2022
VTRS.NB Final Cash Dividend of gross USD 0.12 paid on Dec 16, 2022 going ex on Nov 22, 2022
Nov 23, 2022
Dec 16, 2022
Nov 22, 2022
查看更多
拆合股
公告日期
类型
比率
暂无数据
公告日期
类型
比率
暂无数据
tradingkey.logo
tradingkey.logo
日内数据由路孚特(Refinitiv)提供,并受使用条款约束。历史及当前收盘数据均由路孚特提供。所有报价均以当地交易所时间为准。美股报价的实时最后成交数据仅反映通过纳斯达克报告的交易。日内数据延迟至少15分钟或遵循交易所要求。
* 参考、分析和交易策略由第三方提供商Trading Central提供,观点基于分析师的独立评估和判断,未考虑投资者的投资目标和财务状况。
风险提示:我们的网站和移动应用程序仅提供关于某些投资产品的一般信息。Finsights 不提供财务建议或对任何投资产品的推荐,且提供此类信息不应被解释为 Finsights 提供财务建议或推荐。
投资产品存在重大投资风险,包括可能损失投资的本金,且可能并不适合所有人。投资产品的过去表现并不代表其未来表现。
Finsights 可能允许第三方广告商或关联公司在我们的网站或移动应用程序的任何部分放置或投放广告,并可能根据您与广告的互动情况获得报酬。
© 版权所有: FINSIGHTS MEDIA PTE. LTD. 版权所有
KeyAI